A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2120500
2120500 9306864 PCTABS00021 Compositions and methods for prolonging the function of a transplanted allograft and preventing transplant rejection are provided. Particularly, tolerance is induced in a recipient mammal to a transplanted organ or tissue by treatment with a composition comprising more than one adhesion molecule inhibitor including antibodies to the adhesion molecule and corresponding ligand, e.g. antibodies to LFA-1 and ICAM-1. Compositions of the invention find additional use in treating inflammatory reactions, as well as allergies and autoimmune diseases.
Borden Ladner Gervais Llp
The General Hospital Corporation
LandOfFree
Preventing allograft rejection with antibodies to adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventing allograft rejection with antibodies to adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing allograft rejection with antibodies to adhesion... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1391372